Access cutting-edge solid tumors treatment through this clinical trial at a research site in Nashville. Study-provided care at no cost to qualified participants.
Access solid tumors specialists in Nashville at no cost
This study follows strict safety protocols and ethical guidelines
All study-related solid tumors treatment provided free
This is an open-label, multicenter, Phase 1/2 study evaluating the safety and efficacy of CTX131™ in subjects with relapsed or refractory solid tumors.
Sponsor: CRISPR Therapeutics AG
Check if you qualify for this solid tumors clinical trial in Nashville, TN
If you're searching for solid tumors treatment options in Nashville, TN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Nashville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced solid tumors specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.